Novel virosecurinine bivalent mimetics as potent reversal agents against P-glycoprotein-mediated multidrug resistance
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference70 articles.
1. Cancer multidrug resistance (MDR): a major impediment to effective chemotherapy;Ullah;Asian Pac. J. Cancer Prev. APJCP,2008
2. The impact of melatonin on colon cancer cells’ resistance to doxorubicin in an in vitro study;Fic;Int. J. Mol. Sci.,2017
3. p53 and P-glycoprotein influence chemoresistance in hepatocellular carcinoma;Li;Front. Biosci.,2018
4. Design, synthesis, and pharmacological characterization of N-(4-(2 (6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)yl)ethyl)phenyl)quinazolin-4-amine derivatives: novel inhibitors reversing P-Glycoprotein-Mediated multidrug resistance;Qiu;J. Med. Chem.,2017
5. Ligand-based modeling of diverse aryalkylamines yields new potent P-glycoprotein inhibitors;Alqudah;Eur. J. Med. Chem.,2016
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bioactivities and Mechanisms of Action of Sinomenine and Its Derivatives: A Comprehensive Review;Molecules;2024-01-22
2. Synthesis, biological activity and mechanism of action of novel allosecurinine derivatives as potential antitumor agents;Bioorganic & Medicinal Chemistry;2023-03
3. Bioactivities and mechanism of action of securinega alkaloids derivatives reported prior to 2022;Biomedicine & Pharmacotherapy;2023-02
4. Rational design of phenyl thiophene (pyridine) derivatives that overcome P-glycoprotein mediated MDR in MCF-7/ADR cell;Bioorganic Chemistry;2021-09
5. Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell;European Journal of Medicinal Chemistry;2021-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3